Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS

NCT03561922 is registered in ClinicalTrials.gov with Retina Implant AG as lead sponsor.

NCT NCT03561922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03561922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Lead sponsor
Retina Implant AG
Phase
Not applicable
Overall status
Terminated
Start date
September 4, 2018
Completion date
April 5, 2019
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

inherited retinal dystrophy primarily involving sensory retina, retinal degeneration